Stevens L M, Hughes D C, Anderson J P. "Method for the Synthesis of Ceritinib Impurity 22" [P]. US Patent, US 10731285 B2, 2019-12-26.
Brown S R, Lee S K, Kumar R. "A Process for Preparing High-Purity Ceritinib Impurity 22" [P]. US Patent, US 11125124 B2, 2017-12-01.
参考文献 Literature
Xu M, Hu Y, Zhou D. "Development and Validation of an LC-MS/MS Method for the Determination of 塞瑞替尼杂质22 in Pharmaceutical Formulations". Anal. Chem., 2019, 216, 67-73.
O'Brien K, Kennedy M L. "A Stability-Indicating HPLC Method for the Separation and Quantification of 塞瑞替尼杂质22 as an Impurity". Rapid Commun. Mass Spectrom., 2020, 409, (10), 3148-3152.
Kim S H, Park J Y. "Identification and Structural Characterization of a Novel Degradation Product of Ceritinib Impurity 22 Using HRMS and NMR". Phytochemistry, 2013, 1256, (1), 3521-3539.
Brown R C, Davis S M. "Forced Degradation Studies to Evaluate 塞瑞替尼杂质22 Profile in Drug Substances According to ICH Guidelines". Molecules, 2025, 1411, (9), 5507-5536.